Literature DB >> 28063676

Early predictors for massive transfusion in older adult severe trauma patients.

Takao Ohmori1, Taisuke Kitamura2, Junko Ishihara2, Hirokazu Onishi2, Tsuyoshi Nojima2, Kotaro Yamamoto2, Ryu Tamura2, Kentaro Muranishi2, Toshiyuki Matsumoto3, Takamitsu Tokioka3.   

Abstract

BACKGROUND: Many scoring systems for the early prediction of the need for massive transfusion (MT) have been reported; in most of these, vital signs are regarded as important. However, the validity of these scoring systems in older patients remains unclear because older trauma patients often present with normal vital signs. In this study, we investigated the effectiveness of previously described scoring systems, as well as risk factors that can provide early prediction of the need for MT in older severe trauma patients.
METHODS: We prospectively collected data from a cohort of severe trauma patients (ISS ≥16 and age ≥16years) admitted from January 2007 to March 2015. Trauma Associated Severe Hemorrhage (TASH), Assessment of Blood Consumption (ABC), and Prince of Wales Hospital (PWH) scores were compared between a younger and an older group. Furthermore, the predictors associated with MT in older severe trauma patients were assessed using multivariable logistic regression analyses.
RESULTS: The area under the curve (AUC) was significantly smaller for older group than for younger group for all three scoring systems (p<0.05). The most important risk factors to predict the need for MT were related to anatomical factors including FAST results (odds ratio (OR): 5.58, 95% confidence interval (CI): 2.10-14.99), unstable pelvic fracture (OR: 21.56, 95% CI: 6.05-90.78), and long bone open fracture of the lower limbs (OR: 12.21, 95% CI: 4.04-39.09), along with pre-injury anticoagulant agent use (OR: 5.22, 95% CI: 1.30-19.61), antiplatelet agent use (OR: 3.81, 95% CI: 1.57-9.04), lactate levels (OR: 1.20, 95% CI: 1.04-1.39) and shock index (OR: 2.67, 95% CI: 1.05-6.84). Traditional vital signs were not early risk factors.
CONCLUSION: We suggest that MT in older trauma patients should be considered on the basis of anatomical factors, pre-injury anticoagulant or antiplatelet agent use, lactate level and SI even if traditional vital signs are normal.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Massive transfusion; Older adult; Predictor; Trauma

Mesh:

Year:  2016        PMID: 28063676     DOI: 10.1016/j.injury.2016.12.028

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  6 in total

Review 1.  Transfusion Decision Making in Pediatric Critical Illness.

Authors:  Chris Markham; Sara Small; Peter Hovmand; Allan Doctor
Journal:  Pediatr Clin North Am       Date:  2017-10       Impact factor: 3.278

2.  The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition.

Authors:  Donat R Spahn; Bertil Bouillon; Vladimir Cerny; Jacques Duranteau; Daniela Filipescu; Beverley J Hunt; Radko Komadina; Marc Maegele; Giuseppe Nardi; Louis Riddez; Charles-Marc Samama; Jean-Louis Vincent; Rolf Rossaint
Journal:  Crit Care       Date:  2019-03-27       Impact factor: 9.097

3.  Shock index increase from the field to the emergency room is associated with higher odds of massive transfusion in trauma patients with stable blood pressure: A cross-sectional analysis.

Authors:  Shao-Chun Wu; Cheng-Shyuan Rau; Spencer C H Kuo; Shiun-Yuan Hsu; Hsiao-Yun Hsieh; Ching-Hua Hsieh
Journal:  PLoS One       Date:  2019-04-25       Impact factor: 3.240

4.  The impact of age and receipt antihypertensives to systolic blood pressure and shock index at injury scene and in the emergency department to predict massive transfusion in trauma patients.

Authors:  Se Jin Park; Mi Jin Lee; Changho Kim; Haewon Jung; Seong Hun Kim; Wooyoung Nho; Kang Suk Seo; Jungbae Park; Hyun Wook Ryoo; Jae Yun Ahn; Sungbae Moon; Jae Wan Cho; Shin-Ah Son
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2021-01-30       Impact factor: 2.953

Review 5.  Antiplatelet Therapy for Atherothrombotic Disease in 2022-From Population to Patient-Centered Approaches.

Authors:  Georges Jourdi; Anne Godier; Marie Lordkipanidzé; Guillaume Marquis-Gravel; Pascale Gaussem
Journal:  Front Cardiovasc Med       Date:  2022-01-28

6.  Prognostic Accuracy of Massive Transfusion, Critical Administration Threshold, and Resuscitation Intensity in Assessing Mortality in Traumatic Patients with Severe Hemorrhage: a Meta-Analysis.

Authors:  Wu Seong Kang; In Soo Shin; Jung Soo Pyo; Sora Ahn; Seungwoo Chung; Young Jun Ki; Junepill Seok; Chan Yong Park; Sungdo Lee
Journal:  J Korean Med Sci       Date:  2019-12-30       Impact factor: 2.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.